Here are five things to know:
1. ApiFix also announced the six-year follow-up on the earliest patients treated with the MID-C technology.
2. The MIS posterior dynamic deformity correction system is designed to promote permanent curve correction while retaining spine flexibility.
3. The system is intended to act as an “internal brace” and includes a unidirectional, self-adjusting rod mechanism with motion-preserving polyaxial joints allowing for additional noninvasive postoperative correction over time. The device is removable.
4. More than 100 patients treated with the device have undergone two-year follow-ups. While investigational in the U.S., the device is under review by FDA in a Humanitarian Device Exemption application.
5. The MID-C system has CE Mark approval.
More articles on MIS:
1st patient enrolled in Vertos Medical’s mild procedure study: 4 things to know
Dr. Sukdeb Datta: Key trends in minimally invasive spine surgery and its place in value-based care
Spineology SCOUT study shows positive outcomes for lumbar interbody fusion procedure: 3 findings
